TIM
NBIX icon

Thompson Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Thompson Investment Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Hold
9,755
– – 0.19% 99
2026
Q1 		$1.29M Hold
9,755
– – 0.17% 97
2025
Q4 		$1.38M Hold
9,755
– – 0.17% 97
2025
Q3 		$1.37M Hold
9,755
– – 0.18% 96
2025
Q2 		$1.23M Hold
9,755
– – 0.17% 99
2025
Q1 		$1.08M Buy
9,755
+925
+10% +$117K 0.16% 99
2024
Q4 		$1.21M Sell
8,830
-920
-9% -$114K 0.17% 101
2024
Q3 		$1.12M Buy
9,750
+1,850
+23% +$254K 0.16% 98
2024
Q2 		$1.09M Buy
7,900
+275
+4% +$37.7K 0.17% 96
2024
Q1 		$1.05M Sell
7,625
-75
-1% -$10.2K 0.16% 97
2023
Q4 		$1.01M Sell
7,700
-575
-7% -$66.2K 0.16% 99
2023
Q3 		$931K Sell
8,275
-330
-4% -$34.8K 0.17% 99
2023
Q2 		$811K Buy
8,605
+375
+5% +$36.6K 0.13% 106
2023
Q1 		$833K Buy
8,230
+1,725
+27% +$180K 0.14% 104
2022
Q4 		$777K Hold
6,505
– – 0.14% 109
2022
Q3 		$691K Sell
6,505
-1,300
-17% -$132K 0.13% 111
2022
Q2 		$761K Hold
7,805
– – 0.13% 110
2022
Q1 		$732K Buy
7,805
+500
+7% +$42.4K 0.11% 119
2021
Q4 		$622K Buy
7,305
+375
+5% +$34.5K 0.09% 132
2021
Q3 		$665K Hold
6,930
– – 0.1% 131
2021
Q2 		$674K Buy
6,930
+2,500
+56% +$240K 0.1% 135
2021
Q1 		$431K Hold
4,430
– – 0.07% 153
2020
Q4 		$425K Buy
4,430
+700
+19% +$67.6K 0.07% 143
2020
Q3 		$359K Buy
3,730
+330
+10% +$38.2K 0.07% 142
2020
Q2 		$415K Buy
+3,400
New +$376K 0.08% 136

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Thompson Investment Management's NBIX Position: Q2 2026 in Review

Thompson Investment Management held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 9,755 shares worth $1.64M. The position accounts for 0.19% of the portfolio, ranked #99.

Thompson Investment Management first reported a position in NBIX in Q2 2020 and has held it in 25 quarters since. 108 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Thompson Investment Management held 9,755 shares of Neurocrine Biosciences worth $1.64M as of Q2 2026.
  • Thompson Investment Management left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up 0.19% of Thompson Investment Management's portfolio in Q2 2026, its #99 holding.
  • Thompson Investment Management first reported a position in Neurocrine Biosciences in Q2 2020 and has held it in 25 quarters since.
  • 108 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Thompson Investment Management's 13F filing for Q2 2026, filed 13 Jul 2026.